Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Herbalife (NYSE:HLF) sees Q3 sales of $1.247 billion-$1.296 billion vs $1.241 billion analyst estimate.
Herbalife (NYSE:HLF) raises FY2025 sales outlook from $4.868 billion-$5.118 billion to $4.943 billion-$5.143 billion vs $4.948 ...
Herbalife (NYSE:HLF) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.38 by 56.5 ...
Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $8 to $9.
New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditur...
Certified Method Enhances Global Botanical Quality and Safety
